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the endovascular treatment of complicated type B aortic dissection
using a composite device design
Joseph V. Lombardi, Richard P. Cambria, Christoph A. Nienaber, Roberto
Chiesa, Omke Teebken, Anthony Lee, Peter Mossop, Priya Bharadwaj
Objective: This study evaluates the safety and effectiveness of a unique
composite thoracic endovascular aneurysm repair (TEVAR) construct
(proximal stent graft and distal bare metal stent) for the treatment of
patients with complicated type B aortic dissection (cTBAD).
Methods: In this prospective, single-arm, multicenter study, patients
with cTBAD were treated with an endovascular system consisting of
proximal TX2 thoracic stent grafts and distal bare metal dissection
stents (Zenith Dissection Endovascular System; Cook Medical, Bloo-
mington, Ind). Indications for enrollment were branch vessel malper-
fusion, impending rupture, aortic diameter 40 mm, rapid aortic
expansion, and persistent pain or hypertension despite maximum
medical therapy. One-year follow-up results, including clinical and
radiographic (computerized tomography [CT] and X-ray) evaluation,
were available for this report.
Results: Ten centers enrolled 40 patients (70% men; mean age 58 years
old) between December 2007 and August 2009. The onset of symp-
toms was acute (14 days) in 24 patients (60%), subacute (15-30 days)
in six patients (15%), and chronic (31-90 days) in 10 patients (25%); the
overall mean time from symptom onset to treatment was 20 days
(range, 0-78 days). A majority of patients (77.5%; 31 of 40 patients)
presented with impending aortic rupture (indicated by periaortic
effusion/hematoma) or branch vessel malperfusion. Seven combina-
tions of stent grafts and dissection stents were used, and all devices
were successfully deployed and patent. The 30-day mortality rate was
5% (2 of 40); two deaths occurred after 30 days, leading to a 1-year
survival rate of 90%. Two deaths, occurring at 11 and 81 days post-
procedure, respectively, were secondary to aortic rupture. Morbidity
occurring within 30 days included stroke (7.5%), transient ischemic
attack (2.5%), paraplegia (2.5%), retrograde progression of dissection
(5%), and renal failure (12.5%). Additional morbidity after 30 days
included one case of retrograde progression of dissection and one case
of renal failure. None of the patients with renal failure became dial-
ysis-dependent. Four patients (10%) underwent secondary interven-
tions within 1 year. Favorable aortic remodeling was observed during
the course of follow-up, indicated by an increase in the true lumen
size and a concomitant decrease in the false lumen size along the
dissected aorta, with completely thrombosed thoracic false lumen
observed in 31% of patients at 12 months as compared to 0% at
baseline.q Full articles available online at www.jvascsurg.org
1078-5884/$ e see front matter
doi:10.1016/S1078-5884(12)00051-2Conclusion: Initial data with a composite TEVAR construct have demon-
strated favorable clinical and anatomic results. Continued enrollment and
long-term data are needed to assess the overall effectiveness of this
treatment strategy.
Volume changes in aortic true and false lumen after the “PETTICOAT”
procedure for type B aortic dissection
GermanoMelissano, Luca Bertoglio, Enrico Rinaldi, Efrem Civilini, Yamume
Tshomba, Andrea Kahlberg, Eustachio Agricola, Roberto Chiesa
Background: The PETTICOAT (Provisional ExTension to Induce COmplete
ATtachment) technique may be employed during endovascular treatment
of type B aortic dissection (TBD) using self-expandable bare stents distal to
the covered stent graft placed over the proximal entry tear. The aim of this
study is to evaluate the volume changes of the true (TL) and false lumen
(FL) on computed tomography (CT) scans.
Methods: Since 2005, 25 selected patients received endovascular treatment
for complicated TBD with the PETTICOAT technique employing the Zenith
Dissection Endovascular System (William Cook Europe, Bjaerverskov,
Denmark). Indications to the use of the PETTICOAT technique were the
evidence of clinicalmanifest dynamicmalperfusion in ﬁve cases (20%) and/or
radiologic evidence of TL collapse in 20 cases (80%). Five patientswere treated
within 2 weeks from onset, 13 patients between 2 weeks and 3 months, and
seven patients over 3 months after the initial acute event. The volumetric
analysis of the changes of TL and FL obtained from CT scan performed before
endovascular treatment of TBD, postoperatively and yearly thereafter were
analyzed using the OsiriX software v 3.9 (Pixmeo sarl, Bernex, Switzerland).
Results: Initial clinical (30 days) andmidterm clinical success was observed
in 21 cases (84%) and in 23 cases (92%), respectively. The volumes of the
aortic TL andFLwere evaluatedat30days andmidtermfollow-up (mean, 38
 17 months). The following TL volumes were recorded: baseline 84  29
cm3, postoperative 16731 cm3 (þ98%),1 year 193 46 cm3 (+131%), and 2
years 216  54 cm3 (+140%). The following FL volumes were recorded:
baseline 332 86 cm3, postoperative 286 85 cm3 (14%),1 year 233 81
cm3 (30%), and 2 years 248  112 cm3 (32%). Progressive remodeling of
the TL was recorded over time in both thoracic and abdominal segments
with shrinkage of the FL mainly in the thoracic segment.
Conclusions: These data provide insight into potential therapeutic beneﬁt
of the PETTICOAT technique. A signiﬁcant immediate increase in TL could
be achieved with resolution of all cases of dynamic malperfusion and TL
collapse. A different behavior of volumes in the thoracic and abdominal
segments was observed.
Surgical bypass vs endovascular treatment for patients with supra-
aortic arterial occlusive disease due to Takayasu arteritis
Young-Wook Kim, Dong-Ik Kim, Yang Jin Park, Shin-Seok Yang, Ga-Yeon
Lee, Duk-Kyung Kim, Keonha Kim, Kiick Sung
Abstracts / European Journal of Vascular and Endovascular Surgery 43 (2012) 362e364 363Objective: This study compared treatment outcomes of patients with
supra-aortic arterial (SAA) occlusive disease due to Takayasu arteritis (TA)
treated with bypass surgery or endovascular treatment.
Methods: All patients diagnosed with TA from September 1994 to
November 2010 were identiﬁed using the hospital database. This retro-
spective study included 21 TA patients who underwent endovascular or
surgical intervention due to SAA lesions and four patients who were
referred from other hospitals after endovascular treatment of SAA lesions.
Fifteen arterial lesions in 10 patients were treated with an endovascular
technique, and 24 arteries in 15 patients were reconstructed using bypass
surgery. We performed endovascular intervention for short (<5 cm)
stenotic lesions and bypass surgery for longer occlusive lesions. After
surgical or endovascular intervention, anti-inﬂammatory medication
(steroids, methotrexate, or azathioprine, or both) was given to 12 patients
(48%) with evidence of disease activity for a mean of 4.4  4.5 months
(median, 2.6; range, 1-15 months). We reviewed and compared demo-
graphic and clinical features, lesion characteristics, indications for treat-
ment, and treatment results between the bypass surgery and endovascular
treatment groups. To evaluate the treatment results, we assessed the
patency of reconstructed arteries, recurrent symptoms, and complications
associated with treatment.
Results: During the 194-month study period, 9.6% of TA patients with SAA
lesions required bypass surgery or endovascular treatment. The typical
indication for treatment was brain ischemic symptoms. Two patients were
neurologically asymptomatic but had cervical artery occlusion in
conjunction with an aortic arch aneurysm or symptomatic aortic regur-
gitation. During a mean follow-up of 39.4  44.4 months (median, 23.2;
range, 0.5-178 months), restenosis (>50%) or occlusion of the recon-
structed arteries was observed in eight of 15 arteries (53.3%) in the
endovascular treatment group vs three of 24 (12.5%) in the bypass surgery
group (P = .01; Fisher exact test). More serious complications, such as
intracerebral hemorrhage (n = 2) due to cerebral hyperperfusion syndrome
or cardiac tamponade developed in the surgical bypass group. No opera-
tive deaths occurred in either group.
Conclusions: Surgical or endovascular interventions were required in one
of 10 TA patients with SAA occlusive lesions. Arteries reconstructed after
surgical bypass had superior patency to those reconstructed by endovas-
cular treatment. However, bypass surgery was more likely than endovas-
cular treatment to be accompanied by serious early postoperative
complications.
Carotid endarterectomy in the acute phase of stroke-in-evolution is
safe and effective in selected patients
Guy Leseche, Jean-Marc Alsac, Rabih Houbbalah, Yves Castier, Francis Fady,
Mikael Mazighi, Pierre Amarenco
Objective: This study documented with independent neurologic assess-
ment the 30-day and 90-day outcomes in selected patients with severe
internal carotid artery (ICA) stenosis who underwent carotid endarterec-
tomy (CEA) in the acute phase of stroke-in-evolution (SIE).
Methods: From January 2003 to December 2010, data from patients who
had surgery 2 weeks of a SIE with high-grade carotid stenosis were
extracted from two prospectively collected databases. Clinical assessment
was by the vascular neurologist using the National Institute of Health
Stroke Scale (NIHSS) and the modiﬁed Rankin Scale score. All patients had
computed tomography or magnetic resonance brain imaging 3 hours of
stroke onset. Those eligible received thrombolysis. Duplex ultrasound
imaging was initially used for the diagnosis of severe (60%) ICA stenosis,
and further assessment was by magnetic resonance or computed tomog-
raphy angiography, or both. Perioperativemedical treatment and operative
techniques were standardized. Stroke, death, major cardiac events, and
functional outcome were analyzed.
Results: Twenty-seven patients underwent carotid revascularization in the
acute phase of SIE. Fluctuating or progressive neurologic deﬁcit was the
presenting pattern in 20 patients and occurred after otherwise successful
thrombolytic therapy in the remaining 7 (26%). Median NIHSS score at
admissionwas 8. Median delay to surgery from the index event was 6 days.
The mean degree of ICA stenosis was 87%. All patients received antiplatelet
and statin therapy during the intervening period. Procedures wereconventional CEA with patch angioplasty (polytetraﬂuoroethylene) in 26
patients (96.3%) and redo interposition bypass grafting in 1 patient. CEA
was done under local anesthesia in 23 patients (85.2%), with selective
shunting in 3 (13.0%), and under general anesthesia, with systematic
shunting in 4. At discharge and at 1 and 3 months, no recurrent stroke or
death, and one nonfatal myocardial infarction occurred in this series, with
a 100% complete follow-up. At 3 months, all patients had a favorable
functional outcome deﬁned as a modiﬁed Rankin Scale score of 2.
Conclusions: This short series demonstrates that CEA in the acute phase of
SIE with strict selection criteria and close blood pressure monitoring is
safe, even after recent thrombolytic therapy, and is effective in functional
outcome at 3 months. Larger series of patients are required to conﬁrm the
safety and efﬁcacy of this management.
Surgical trainee participation during infrainguinal bypass grafting
procedures is associated with increased early postoperative graft
failure
John E. Scarborough, Theodore N. Pappas, Mitchell W. Cox, KylaM. Bennett,
Cynthia K. Shortell
Objective: This study was conducted to determine the potential effect of
surgical trainee participation during infrainguinal bypass procedures on
postoperative graft patency rates.
Methods: Data from the National Surgical Quality Improvement Program
(NSQIP) Participant User Files from 2005 through 2009 were retrospec-
tively reviewed, using propensity score matching, to identify all patients
undergoing infrainguinal bypass grafting procedures, excluding those who
had prior operation 30 days of the index procedure. A separate analysis
was performed on a subset of procedures from the entire NSQIP sample
that was matched on propensity for intraoperative surgical trainee
participation. The primary predictor variable was intraoperative surgical
trainee participation. The main outcome measure was the 30-day post-
operative graft failure rate.
Results: For the entire sample of 14,723 NSQIP patients undergoing
infrainguinal bypass grafting, 30-day graft failure rates were signiﬁcantly
higher when a surgical trainee participated (5.8%) vs without participation
(3.9%; P < .0001). For the cohort of 9234 patients matched on their
propensity for intraoperative trainee participation, this difference in graft
failure rate remained signiﬁcant (5.0% with participation vs 4.0% without
participation; P = .02).
Conclusions: Surgical trainee participation is an independent risk factor
for technical failure after infrainguinal bypass grafting. Prospective eval-
uation is needed to determine the cause of this increase in graft failure
rates for procedures that involve surgical trainees.
The impact of adjunctive iliac stenting on femoral-femoral bypass in
contemporary practice
Chetan P. Huded, Philip P. Goodney, Richard J. Powell, Brian W. Nolan, Eva
M. Rzucidlo, Samuel T. Simone, Daniel B. Walsh, David H. Stone
Objectives: Most reports of femoral-femoral bypass (FFB) were published
before the era of endovascular intervention. This study examines the
utilization and impact of adjunctive endovascular intervention on FFB in
contemporary practice.
Methods: We reviewed 253 FFB performed in 247 patients between 1984
and 2010. Primary endpoints, including graft patency, primary-assisted
patency, limb salvage, and survival, were assessed using Kaplan-Meier life-
table analysis. Univariate and multivariate analyses were performed to
determine predictors of primary endpoints.
Results: The indication for FFB included claudication (27%; n = 69) and
critical limb ischemia (72%; n = 184). Forty-eight patients (19%) were
treated urgently for acute ischemia. Mean follow-up was 5.6  5.5 years.
Over the study interval, adjunctive iliac percutaneous transluminal
angioplasty (PTA)/stent placement increased signiﬁcantly from 0% to 54%
(P trend < .001), while the rate of axillofemoral bypass or no inﬂow
procedure decreased from 100% to 46% (P trend < .001). Despite increased
utilization, iliac PTA/stenting was associated with decreased 5-year
primary graft patency of 44% compared with 74% for axillofemoral bypass
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.004). Patients with inﬂow iliac PTA/stents also had diminished 5-year
assisted primary patency of 61% compared with 85% for axillofemoral
bypass patients and 87% in patients without inﬂow revascularization (P =
.002). Adjunctive iliac PTA/stenting did not impact limb salvage or overall
survival. Five-year primary patency among claudicants and critical leg
ischemia patients was 65% and 68%, respectively.
Conclusions: The incidence of iliac PTA/stent placement in conjunction
with FFB has increased signiﬁcantly over time in contemporary practice.
Reliance on iliac stent placement for FFB inﬂow is paradoxically associated
with both diminished primary and assisted primary graft patency when
compared with historical controls. These ﬁndings highlight the impor-
tance of patient selection and inﬂow consideration when performing FFB.
Twenty-year experience in vein bypasses to branches of pedal
arteries
Francisco Cardoso Brochado-Neto, Marcus Vinícius Martins Cury, Suellen
Stevam Timotheo Bonadiman, Marcelo Fernando Matielo, Sérgio Roberto
Tiossi, Marcos Roberto Godoy, Katsumi Nakano, Roberto Sacilotto
Objective: We report a retrospective analysis of our experience in bypass
vein graft surgery to lateral tarsal, medial plantar, and lateral plantar
arteries for treatment of critical limb ischemia (CLI).
Methods: Between January 1991 and February 2010, we performed 137
inframalleolar bypass graft surgeries; of these, 25 (18%) were conducted
using foot branch arteries for distal implant. All patients were treated for
CLI and most had extensive infrapopliteal atherosclerotic disease (Trans-
Atlantic Inter-Society Consensus D). Mean follow-up was 46.32 months
(range, 0-144 months). Main end points analyzed were cumulative
patency, limb salvage, and survival. Statistic analysis of all end points was
performed using Kaplan-Meier survival curves.
Results: There was a predominance of men (64%), and the group mean age
was 66.3 years. Diabetes mellitus was the main associated disease. Eighty
percent of ulcers or gangrene were restricted to the midfoot (Rutherford V
CLI classiﬁcation). There was a predominance of short-length grafts using
the great saphenous vein as the main conduit (72%). The medial plantar
artery was the main outﬂow artery (52%). Early graft occlusion occurred in
four patients (primary failure rate, 16%). Secondary patency at 1 and 3
years was 49% and 36.8%, respectively, and limb salvagewas 81.7% and 69%,
respectively. Nine major amputations occurred, and 10 other minor
amputations were necessary. Survival rate at 3 years was 65.4%, and 67% ofpatients maintained ambulation. Surgical mortality was 8%. No condition
was associated with worse results with regard to secondary patency, limb
salvage, or survival.
Conclusions: Long-term results for developed foot branch bypass
demonstrated good results for limb salvage, and it is an acceptable surgery
for patients with extensive atherosclerotic disease.
Technique, results, and postoperative patency of lymphaticovenous
side-to-end anastomosis in peripheral lymphedema
Jiro Maegawa, Yuichiro Yabuki, Hiroto Tomoeda, Misato Hosono, Kazunori
Yasumura
Objective: Lymphaticovenous anastomosis has been used for patients with
peripheral lymphedema. However, the efﬁcacy of this procedure is
controversial due to a lack of evidence regarding postoperative patency.
We sought to determine midterm postoperative patency of lymphatico-
venous side-to-end anastomoses (LVSEAs) using indocyanine green ﬂuo-
rescence lymphography.
Methods: This was a retrospective observational study set in a teaching
hospital. Of 107 patients with chronic lymphedema who underwent 472
LVSEAs, 57 (223 anastomoses) consented to ﬂuorescence lymphography
and comprised the study cohort. The intervention consisted of a micro-
surgical LVSEA performed with a suture-stent method. Patients also had
preoperative and postoperative complex decongestive physiotherapy.
Anastomosis patency was assessed using indocyanine green ﬂuorescence
lymphography 6 months after surgery. Patency rates were calculated
using Kaplan-Meier analysis. We assessed volume reduction on the oper-
ated-on limb and compared this between patients in whom anastomoses
were patent and those in whom anastomoses were not obviously patent.
Results: Patency could be evaluated only at the dorsum of the foot, ankle,
and lower leg because the near-infrared rays emitted by the special camera
used could not penetrate the deep subcutaneous layer containing collective
lymphatics in areas such as the thigh. Several patterns were observed on
ﬂuorescence lymphography: straight, radial, and L-shaped. Cumulative
patency rates of LVSEAs were 75% at 12months and 36% at 24months after
surgery. No signiﬁcant difference in volume change of the affected limbwas
seen between the 34 patients with patent anastomosis (600 969mL) and
the 24 patients without obvious evidence of patency (420  874 mL).
Conclusions: Although further study is required to determine factors
leading to anastomotic obstruction and to optimize the results of micro-
lymphatic surgery, the present LVSEA technique appears promising.
